Abstract
A potent series of substituted 2-phenyl-2H-indazole-7-carboxamides were synthesized and evaluated as inhibitors of poly (ADP-ribose) polymerase (PARP). This extensive SAR exploration culminated with the identification of substituted 5-fluoro-2-phenyl-2H-indazole-7-carboxamide analog 48 which displayed excellent PARP enzyme inhibition with IC(50)=4nM, inhibited proliferation of cancer cell lines deficient in BRCA-1 with CC(50)=42nM and showed encouraging pharmacokinetic properties in rats compared to the lead 6.
Copyright 2009 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemical synthesis*
-
Amides / chemistry
-
Amides / pharmacology
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Azetidines / chemical synthesis*
-
Azetidines / chemistry
-
Azetidines / pharmacology
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
HeLa Cells
-
Humans
-
Indazoles / chemical synthesis*
-
Indazoles / chemistry
-
Indazoles / pharmacology
-
Poly(ADP-ribose) Polymerase Inhibitors*
-
Poly(ADP-ribose) Polymerases / metabolism
-
Rats
-
Structure-Activity Relationship
-
Ubiquitin-Protein Ligases / deficiency
-
Ubiquitin-Protein Ligases / genetics
-
Ubiquitin-Protein Ligases / metabolism
Substances
-
Amides
-
Antineoplastic Agents
-
Azetidines
-
Enzyme Inhibitors
-
Indazoles
-
Poly(ADP-ribose) Polymerase Inhibitors
-
BRAP protein, human
-
Ubiquitin-Protein Ligases
-
Poly(ADP-ribose) Polymerases